Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,248Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Onfi

PharmaCompass

01

Brand Name : Onfi

Clobazam

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Onfi

arrow
2024 ACI Convention
Not Confirmed

Clobazam

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 104

2019 Revenue in Millions : 171

Growth (%) : -39

blank

02

Brand Name : Onfi

Clobazam

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Onfi

arrow
2024 ACI Convention
Not Confirmed

Clobazam

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 77

2020 Revenue in Millions : 103

Growth (%) : -21

blank

03

Brand Name : Onfi

Clobazam

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Onfi

arrow
2024 ACI Convention
Not Confirmed

Clobazam

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 61

2021 Revenue in Millions : 77

Growth (%) : -20

blank

04

Brand Name : Onfi

Clobazam

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Onfi

arrow
2024 ACI Convention
Not Confirmed

Clobazam

Main Therapeutic Indication : Neuroscience and Mental Health

Currency : USD

2015 Revenue in Millions : 138

2014 Revenue in Millions : 264

Growth (%) : 91%

blank

05

Brand Name : Onfi

Clobazam

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Onfi

arrow
2024 ACI Convention
Not Confirmed

Clobazam

Main Therapeutic Indication : Neuroscience/Mental Health

Currency : USD

2014 Revenue in Millions : 61%

2013 Revenue in Millions :

Growth (%) :

blank

06

Brand Name : Onfi

Clobazam

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Onfi

arrow
2024 ACI Convention
Not Confirmed

Clobazam

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 514

2016 Revenue in Millions : 410

Growth (%) : 25

blank

07

Brand Name : Onfi

Clobazam

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Onfi

arrow
2024 ACI Convention
Not Confirmed

Clobazam

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 475

2017 Revenue in Millions : 453

Growth (%) : 5%

blank

08

Brand Name : Onfi

Clobazam

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Onfi

arrow
2024 ACI Convention
Not Confirmed

Clobazam

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 158

2018 Revenue in Millions : 475

Growth (%) : -67

blank